JY
SLXP

Jeff Yass’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Jeff Yass’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,601,900
Closed -$277M – 10865
2015
Q1 		$277M Buy
1,601,900
+347,300
+28% +$51M 0.13% 132
2014
Q4 		$144M Buy
1,254,600
+703,300
+128% +$85.2M 0.06% 297
2014
Q3 		$86.1M Buy
551,300
+166,100
+43% +$24.1M 0.03% 472
2014
Q2 		$47.5M Buy
385,200
+271,800
+240% +$30M 0.02% 729
2014
Q1 		$11.7M Sell
113,400
-193,700
-63% -$19.8M 0.01% 1832
2013
Q4 		$27.6M Buy
307,100
+31,600
+11% +$2.52M 0.01% 1076
2013
Q3 		$18.4M Buy
275,500
+238,100
+637% +$16.4M 0.01% 1282
2013
Q2 		$2.47M Buy
+37,400
New +$2.14M ﹤0.01% 3588

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $487M AUM 49.37% 1-Year Est. Return

Jeff Yass's SLXP Position: Q2 2015 in Review

Jeff Yass sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 41,580 shares — an estimated $7.19M sold.

Jeff Yass first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $57.7M in Q3 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Jeff Yass reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Jeff Yass sold 41,580 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $7.19M.
  • Jeff Yass first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
  • Jeff Yass's SALIX PHARMACEUTICALS LTD DEL position peaked at $57.7M in Q3 2014.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Susquehanna International Group's 13F filing for Q2 2015, filed 14 Aug 2015.